LYSO-PAF16;
Ethanaminium, 2-[[[(2R)-3-(hexadecyloxy)-2-hydroxypropoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt;
1-hexadecyl-sn-glycero-3-phosphocholine;
1-hexadecyl;
1-O-hexadecyl lyso PAF;
C16 LYSO PAF;
1-O-hexadecyl lyso platelet-activating factor;
1-O-PALMITYL-SN-GLYCERO-3-PHOSPHOCHOLINE;
lysophosphatidylcholine O-16:0/0:0;
1-O-hexadecyl-2-lyso-sn-glycero-3-phosphocholine;
(2R)-3-(Hexadecyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate;
1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine;
LYSO-PLATELET ACTIVATING FACTOR;
MFCD00042932;
1-alkyl-2-hydroxy-sn-glycero-3-phosphocholine;
LYSO-PLATELET ACTIVATING FACTOR-16;
1-Hexyldecyl-sn-glycerol-3-phosphorylcholine;